Noticeable, GF109203X treatment also increased Sp1 protein levels in SH-SY5Y human neuroblastoma cells, effect that was completely abolished by PI3K inhibition (see supplementary Fig. S1C). This evidence concerns the gene SP1 and neuroblastoma.